Shaw RJ - Search Results

1

Real-world experience with caplacizumab in the management of acute TTP.

Dutt T, Shaw RJ, Stubbs M, Yong J, Bailiff B, Cranfield T, Crowley MP, Desborough M, Eyre TA, Gooding R, Grainger J, Hanley J, Haughton J, Hermans J, Hill Q, Humphrey L, Lowe G, Lyall H, Mohsin M, Nicolson PLR, Priddee N, Rampotas A, Rayment R, Rhodes S, Taylor A, Thomas W, Tomkins O, Van Veen JJ, Lane S, Toh CH, Scully M. Dutt T, et al. Among authors: shaw rj. Blood. 2021 Apr 1;137(13):1731-1740. doi: 10.1182/blood.2020007599. Blood. 2021. PMID: 33150355 Free article.

2

Circulating histones play a central role in COVID-19-associated coagulopathy and mortality.

Shaw RJ, Abrams ST, Austin J, Taylor JM, Lane S, Dutt T, Downey C, Du M, Turtle L, Baillie JK, Openshaw PJM, Wang G, Semple MG, Toh CH. Shaw RJ, et al. Haematologica. 2021 Sep 1;106(9):2493-2498. doi: 10.3324/haematol.2021.278492. Haematologica. 2021. PMID: 33832219 Free PMC article. No abstract available.

3

Intracranial hemorrhage in immune thrombotic thrombocytopenic purpura treated with caplacizumab.

Schofield J, Shaw RJ, Lester W, Thomas W, Toh CH, Dutt T. Schofield J, et al. Among authors: shaw rj. J Thromb Haemost. 2021 Aug;19(8):1922-1925. doi: 10.1111/jth.15363. Epub 2021 Jun 9. J Thromb Haemost. 2021. PMID: 33974343 Free article. No abstract available.

4

COVID-19 and immunothrombosis: emerging understanding and clinical management.

Shaw RJ, Bradbury C, Abrams ST, Wang G, Toh CH. Shaw RJ, et al. Br J Haematol. 2021 Aug;194(3):518-529. doi: 10.1111/bjh.17664. Epub 2021 Jul 7. Br J Haematol. 2021. PMID: 34114204 Review.

5

A single 1 g/kg dose of intravenous immunoglobulin is a safe and effective treatment for immune thrombocytopenia; results of the first HaemSTAR 'Flash-Mob' retrospective study incorporating 961 patients.

HaemSTAR Collaborators. HaemSTAR Collaborators. Br J Haematol. 2022 Jan;196(2):433-437. doi: 10.1111/bjh.17692. Epub 2021 Dec 3. Br J Haematol. 2022. PMID: 34859421 No abstract available.

6

Diagnostic uncertainty presented barriers to the timely management of acute thrombotic thrombocytopenic purpura in the United Kingdom between 2014 and 2019.

HaemSTAR Collaborators. HaemSTAR Collaborators. J Thromb Haemost. 2022 Jun;20(6):1428-1436. doi: 10.1111/jth.15681. Epub 2022 Mar 11. J Thromb Haemost. 2022. PMID: 35189012 Free PMC article.

7

Mind and matter: The neurological complications of thrombotic thrombocytopenic purpura.

Shaw RJ, Dutt T. Shaw RJ, et al. Br J Haematol. 2022 Jun;197(5):529-538. doi: 10.1111/bjh.18127. Epub 2022 Mar 11. Br J Haematol. 2022. PMID: 35277972 Review.

8

Integrating psychology services for patients with thrombotic thrombocytopenic purpura: A specialist centre experience.

Shaw RJ, Bell J, Poole J, Feely C, Chetter J, Dutt T. Shaw RJ, et al. EJHaem. 2023 Jul 1;4(3):872-875. doi: 10.1002/jha2.726. eCollection 2023 Aug. EJHaem. 2023. PMID: 37601845 Free PMC article.

9

Damage-associated cellular markers in the clinical and pathogenic profile of vaccine-induced immune thrombotic thrombocytopenia.

Abrams ST, Du M, Shaw RJ, Johnson C, McGuinness D, Schofield J, Yong J, Turtle L, Nicolson PLR, Moxon C, Wang G, Toh CH. Abrams ST, et al. Among authors: shaw rj. J Thromb Haemost. 2024 Apr;22(4):1145-1153. doi: 10.1016/j.jtha.2023.12.008. Epub 2023 Dec 15. J Thromb Haemost. 2024. PMID: 38103733 Free article.

10

The Highs and Lows of ADAMTS13 Activity.

Shaw RJ, Abrams ST, Badu S, Toh CH, Dutt T. Shaw RJ, et al. J Clin Med. 2024 Aug 30;13(17):5152. doi: 10.3390/jcm13175152. J Clin Med. 2024. PMID: 39274365 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

554 results

Search Page

Filters